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Abstract
Background: Gamma-aminobutyric acid type B (GABAB) receptors decrease neural activity through G protein signaling.
There are two subunits, GABAB1 and GABAB2. Alternative splicing provides GABAB1 with structural and functional diversity.
cDNA microarrays showed strong signals from human brain RNA using GABAB1 intron 4 region probes. Therefore, we
predicted the existence of novel splice variants.
Methodology/Principal Findings: Based on the probe sequence analysis, we proposed two possible splice variants,
GABAB1j and GABAB1k. The existence of human GABAB1j was verified by quantitative real-time PCR, and mouse GABAB1j
was found from a microarray probe set based on human GABAB1j sequence. GABAB1j open reading frames (ORF) and
expression patterns are not conserved across species, and they do not have any important functional domains except sushi
domains. Thus, we focused on another possible splice variant, GABAB1k. After obtaining PCR evidence for GABAB1k
existence from human, mouse, and rat, it was cloned from human and mouse by PCR along with three additional isoforms,
GABAB1l, GABAB1m, and GABAB1n. Their expression levels by quantitative real-time PCR are relatively low in brain although
they may be expressed in specific cell types. GABAB1l and GABAB1m inhibit GABAB receptor-induced G protein-activated
inwardly rectifying K
+ channel (GIRK) currents at Xenopus oocyte two-electrode voltage clamp system.
Conclusions/Significance: This study supports previous suggestions that intron 4 of GABAB1 gene is a frequent splicing
spot across species. Like GABAB1e, GABAB1l and GABAB1m do not have transmembrane domains but have a dimerization
motif. So, they also could be secreted and bind GABAB2 dominantly instead of GABAB1a. However, only GABAB1l and
GABAB1m are N- and C-terminal truncated splicing variants and impair receptor function. This suggests that the intron 4
containing N-terminal truncation is necessary for the inhibitory action of the new splice variants.
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Introduction
The GABAB receptor is a metabotropic receptor that is highly
expressed in brain and weakly expressed in heart, small intestine,
uterus and other tissues [1]. The functional receptor is a hetero-
oligomer of GABAB1 and GABAB2 subunits, where the
intracellular domain of GABAB1 dimerizes with GABAB2. GABA
binds to the extracellular domain of GABAB1 and transfers signals
through G proteins. G protein a subunits are linked with adenylyl
cyclase (AC), and G protein bc subunits alter Ca
2+ channels and
GIRK channels. The GABAB receptor decreases the activity
of AC and decreases neurotransmitter release by inhibiting Ca
2+
influx through presynaptic Ca
2+ channels. At postsynaptic
neurons, it activates K
+ channels, and an outward K
+ current
induces hyperpolarization preventing Na
+ channel opening and
action potential firing [2]. Thus, the GABAB receptor mediates an
inhibitory neurotransmission.
GABAB1 has two major splicing variants, GABAB1a and
GABAB1b, in the human central nervous system. GABAB1a is
the longest form and has 23 exons (Figure 1A). GABAB1b is an
N-terminal truncated form of GABAB1a and has an alternative
exon from intron 5 resulting in a unique N-terminal without sushi
domains (Figure 1A, B). GABAB1a and b are the most widely
studied isoforms to date and show some distinct expression
patterns in brain as GABAB1a is more presynaptic in localization,
and GABAB1b is more postsynaptic [3,4,5]. However, the
differences in their localization and function are still not known
precisely [4]. Additional splice variants of GABAB1 have been
reported although some were found only in one species, and most
do not have defined functions [3,6,7]. Human GABAB1c lacks
exon 4 (Figure 1A), and its functions have not been studied in
detail [4]. Human GABAB1e is mainly expressed in peripheral
tissues. Because it lacks exon15, GABAB1e is a C-terminal
truncated form of GABAB1a and does not have seven transmem-
brane domains, a G-protein coupling region, nor a C-terminal
intracellular region (Figure 1A, B). However, it is functionally
active and prevents GABAB1a and GABAB2 heterodimerization
[8]. In rat, the GABAB1j isoform was recently discovered and
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14044Figure 1. Schematic summary of GABAB1 isoforms. A. Introns and exons of known and novel GABAB1 isoforms were compared. The numbers
listed at the top are exon numbers of GABAB1a. Blocks represent exons, and lines are introns of the GABAB1 gene. Black lines and blocks are ORFs,
and grey lines and blocks are UTRs. Double line is cDNA microarray probe, clone 300899, which aligns to the intron 4 of GABAB1a. Human GABAB1a,
b, c, e, and rat GABAB1j are previously identified isoforms. After cloning, the following novel isoforms were found in human: GABAB1k, GABAB1l,
GABAB1m, and GABAB1n. Human GABAB1j was predicted. Mouse GABAB1j and GABAB1k were also cloned. GABAB1k contains the 39 part of intron 4
through exon 23. GABAB1l has additional splicing out of exon 15, and GABAB1m has similar splicing patterns as GABAB1l except for additional
splicing out at 59 part of exon 6. GABAB1n has an SNP on exon 8. B. ORFs of GABAB1 isoforms are shown with important functional domains. Black
bars are previously known isoforms, and grey bars represent novel isoforms. Dotted lines stand for unique sequence of each isoform. GABAB1k
contains GABA binding sites, seven transmembrane domains, a G-protein coupling region, and a C-terminal intracellular region. GABAB1l and
GABAB1m do not have transmembrane domains, a G-protein coupling region, or C-terminal intracellular regions (same as GABAB1e). GABAB1m has a
longer N-terminal than GABAB1l. GABAB1n contains only a partial GABA binding site.
doi:10.1371/journal.pone.0014044.g001
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contains exon 1 through 4 and the 59 part of intron 4 and is thus a
small C-terminal truncated GABAB1 isoform (Figure 1A). The
GABAB1j is a soluble isoform with sushi domains (Figure 1B),
which selectively impair the function of presynaptic (but not
postsynaptic) GABAB receptors [7]. Thus, alternative splicing
provides a large diversity of structural and functional variation in
GABAB1 receptors.
The diversity of GABAB1 receptors is indicated by these
previous studies, and it is possible that additional unknown
isoforms exist. Two previous cDNA microarray studies found
strong GABAB1 signals in human brain mRNA [9,10]. The two
probe sequences used in these studies, NCBI accession numbers
N80593 and W07715, were obtained from one single probe with
clone ID 300899. The probe aligns to intron 4 of GABAB1a. This
is a common intron region of the major human GABAB1 splice
variants (Figure 1A) and has been noted as a potentially important
location for alternative splicing in rat [6]. Because the probe was
made from a cDNA library, the probe region should be an
alternative exon in the GABAB1 gene suggesting the existence of
novel GABAB1 isoforms. The goals of this study were to identify
the novel isoforms and determine their functions.
Results
Microarray probe sequence analysis
The expression of clone 300899 increased significantly in
human prefrontal cortices in two independent microarray studies
[9,10], and the clone aligned to the intron 4 region (Figure 1A).
Sequencing of clone 300899 showed multiple stop codons from all
six translated frames and likely represented untranslated region
(UTR)s. Thus, two possible isoform models, GABAB1j and
GABAB1k, were proposed for human allowing us to study novel
GABAB1 splicing variant isoforms. Human GABAB1j and
GABAB1k contain clone 300899 at their 39 and 59 UTR,
respectively. In human brain, GABAB1k was expected to have
intron 4 and exon 5 through 23, and GABAB1j was also proposed
to contain exon 1 through 4 and intron 4 like rat GABAB1j.
GABAB1j: Cloning and mRNA levels in human and mouse
brain
GABAB1j was previously cloned in rat, but not in human or
mouse. Rat GABAB1j ORF is 229 amino acids (aa) (Figure 2A) [7].
Though the predicted human GABAB1j has some different aa
sequences and a shorter ORF of 190 aa, it shares similar motifs with
Figure 2. Sequences for human, mouse, and rat GABAB1j isoforms and relative expression levels. A. Sequence alignment of human,
mouse, and rat GABAB1j showed a different C-terminal pattern in human GABAB1j. B. Human and mouse GABAB1j mRNA expression levels were
measured with quantitative real-time PCR. GB1 primer and probe sets were used to detect most known major GABAB1 isoforms except GABAB1j.
Human and mouse GABAB1j primer and probe sets were specific for only GABAB1j. GB1 expressions were shown as fold differences from human and
mouse GABAB1j. Although a previous rat GABAB1j study indicated that GB1 and GABAB1j expression levels were similar, human and mouse GABAB1j
expressions were lower than GB1. Mouse GABAB1j expression was 5.5 fold lower than GB1 expression, and human GABAB1j showed 135.89 fold
lower expression. If the fold differences were compared, human GABAB1j expression level was much less (25 times) than mouse GABAB1j expression.
Therefore, GABAB1j expressions vary across species.
doi:10.1371/journal.pone.0014044.g002
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important functional domains of common GABAB1 isoforms.
Although human GABAB1a has 23 exons, it has only the first 4
exons and partial 59 intron 4 (Figure 1A). Two novel clones were
found from the mouse cDNA microarray probe set after comparing
sequences with the possible human GABAB1j [11]. The lengths of
the two clones are different because their UTR lengths are not the
same, but they shared identical ORF. They have the same exon
composition and ORF length as rat GABAB1j. Sequencing
alignment also showed that mouse GABAB1j shares the similar
ORF except a few aa differences (Figure 2A).
The intron 4 sequence of the predicted human GABAB1j is
different from mouse and rat GABAB1j. Therefore, sequence
alignment showed that it has a very unique C-terminal and a 39 aa
shorter ORF than mouse and rat GABAB1j (Figure 2A). To do
quantitative real-time PCRs, primer and probe sets for general
GABAB1 isoform (GB1) were designed between the last two exons
of GABAB1a, exon 22 and 23, and they were specific for most
known GABAB1 isoforms except GABAB1j. GABAB1j specific
primer and probe sets were also prepared. Using quantitative real-
time PCR, the existence of the predicted human GABAB1j was
verified. Relative mouse GABAB1j mRNA expression level was
much higher than human GABAB1j when compared to GB1
expression (Figure 2B). GB1 sets and the northern blot probe of
the rat GABAB1j paper [7] were supposed to detect the same
major known isoforms. Though rat GABAB1j expression level in
brain were as high as GB1, human and mouse GABAB1j
expression were less than GB1 expression (Figure 2B).
GABAB1j function in human and rodent might not be identical
because of their expression and sequence differences. Rat
GABAB1j expression is as strong as major GABAB1 isoforms
[7]. Though mouse GABAB1j expression is only 5.5 fold lower
than them (Figure 2B), human GABAB1j showed much lower
expression (136 fold) (Figure 2C). If the fold differences were
compared, the relative human GABAB1j expression level to GB1
was also dramatically less (25 times) than mouse GABAB1j
expression though identical detection regions were used for both
expression studies. Thus, GABAB1j expressions are not consistent
across species. Interestingly, the C-terminal sequence of human
GABAB1j did not share a common pattern with mouse and rat
GABAB1j (Figure 2A). From previous research, purified sushi
domains of rat GABAB1j impaired the inhibitory effect of the
GABAB receptor, but the function of rat GABAB1j full ORF had
not been studied in detail [7]. So, it is not clear whether GABAB1j
functions could be conserved across species.
GABAB1k sequence analysis in human, mouse, and rat
The predicted human GABAB1k is an N-terminal truncated
splicing variant. It contains 39 part of intron 4 and exons 5 through
23, and the ORF was 784 aa (Figure 1A). It had important
functional domains, such as GABA binding sites (Ser70, Tyr190,
and Asp295), seven transmembrane domains (415–677 aa), a G-
protein coupling region (linker region between transmembrane
domain 3 and 4), and a C-terminal intracellular region (678–784
aa: dimerize with GABAB2) (Figure 1B). It shared most domains
with GABAB1b, a functional receptor subunit that had no the
sushi domains [12] (Figure 1B). Thus, GABAB1k might also be a
functional receptor subunit with greater physiological effect than
human GABAB1j, given that GABAB1j only contains the sushi
domains (without any important domains of GABAB1b) and
exhibits much lower relative expression in human than in mouse
and rat. Therefore, we decided to focus on the longer splice
variant GABAB1k instead of the very short splice variant
GABAB1j.
Before cloning the predicted GABAB1k, its existence was
verified in human, mouse, and rat. First, mRNAs containing
microarray probe region, clone 300899, were detected across
species. After purifying total RNA from human cultured cell lines,
mouse midbrain, and rat hippocampus, DNase treatment removed
possible genomic DNA contamination. After making mRNA
specific cDNA with oligo(dT) primer, PCRs were performed
within the probe regions. Three different clones (#2, #3, and #4)
were isolated from human (Figure 3). After probe homologous
regions in mouse and rat were found with Blast N Search, #11
and #18 were cloned in mouse and rat, respectively (Figure 3).
The previous microarray probe sequence analysis proved that the
microarray probe was a part of intron 4 and either 39 or 59 UTR
of novel isoforms. Because there was no known human GABAB1
isoform that had the intron 4 region as an exon, the two possible
clones, GABAB1j and GABAB1k, were predicted to contain the
intron 4 regions as 39 or 59 UTR, respectively. GABAB1j and
GABAB1k were also only possible isoform models that contain the
microarray probe in intron 4. Thus, #2, #3, #4, #11, and #18
can be partial GABAB1j or GABAB1k, and mRNAs containing
the probe regions exist in human, mouse, and rat.
To confirm the predicted GABAB1k existence and to remove
the possibility of genomic DNA contamination, PCRs were per-
formed between the probe region and other exons. Partial
GABAB1k forms containing exon-intron junctions were also
cloned from human cultured cell lines, mouse midbrain, and rat
hippocampus. There were six different N-terminal partial clones,
#5-1, #5-2, #6-1, #6-2, #12, and 17&19 (Figure 3). They share
the partial ORF sequences of other known isoforms in the N-
terminal and also have common 59 UTRs. There is no possibility
of genomic DNA contamination because introns are spliced out.
Thus, the N-terminal partial clones suggested that GABAB1k
exists. They are not long enough to have other functional domains,
such as transmembrane domains, a G-protein coupling region,
and a C-terminal intracellular region. It was, thus, necessary to
obtain the full ORF for functional study of GABAB1k.
Cloning GABAB1k, GABAB1l, GABAB1m, and GABAB1n
To clone the full ORF, additional primers were designed at the
possible 39 UTR of the predicted GABAB1k based on known
isoform sequence analysis. From human whole brain and mouse
midbrain, several clones were detected by PCR. They were a&b,
a&7, 3&7, and c&d (Figure 3). The expected human GABAB1k
and mouse GABAB1k were cloned. They have the 39 part of
intron 4 through exon 23 (Figure 1A). They are an N-terminal
truncated splicing variant isoforms, and their ORFs are 784 aa.
They contain functional domains, such as GABA binding sites,
seven transmembrane domains, a G-protein coupling region, and
a C-terminal intracellular region (Figure 1B).
In addition to GABAB1k, two other forms, GABAB1l and m,
were also cloned in human. GABAB1l has additional splicing out of
exon15andisbothN-terminalandC-terminaltruncated(Figure1A,
B). The C-terminal truncated pattern is the same as GABAB1e [8],
and its ORF is 401 aa. Though it contains GABA binding sites, it
does not have the other functional domains (Figure 1B). GABAB1m
has almost the same splicing pattern as GABAB1l except for an
additional missing at 59 part of exon 6 (Figure 1A). Thus, its ORF is
longer (423 aa) than human GABAB1land starts at intron 4 whereas
the ORFs of GABAB1k begin at exon 6 (Figure 1B).
During cloning, one more isoform, GABAB1n, was also found.
It has a single nucleotide polymorphism (SNP) at exon 8 and so
has a very small ORF, 107 aa. It does not have any important
functional domains except a partial GABA binding site (Ser70)
(Figure 1A, B).
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PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e14044Figure 3. Strategy for cloning GABAB1k. The top figure represents exon-intron composition of the proposed GABAB1k. Numbered rectangular
boxes represent known exons, and lines between boxes are introns. Two arrows on the bottom of the boxes represent ORF. Black bar is intron 4, and
the two probe sequence data, NCBI accession numbers W07715 and N80593, are indicated as #1 and #2 above small rectangular boxes, respectively.
They are 59 and 39 sequences of the microarray probe, clone 300899. A arrow above the black bar is a possible transcription initiation site. Horizontal
lines indicate sequences detected after PCR. Based on microarray probe, clone 300899, the following clones were detected in human cultured cells,
mouse midbrain, and rat hippocampus: #2, #3, #4, #11, and #18. From the previous microarray probe sequence analysis, the microarray probe
aligned to intron 4 and was either 39 or 59 UTR of novel isoforms. Because there was no known human GABAB1 isoform that had intron 4 as an exon,
the two possible isoform models, GABAB1j and GABAB1k, were proposed. The predicted GABAB1j and GAGAG1k contain intron 4 as 39 or 59 UTR,
respectively. Because GABAB1j and GABAB1k are only two possible isoform models that contain clone 300899, #2, #3, #4, #11, and #18 can be
partial GABAB1j or GABAB1k and show their existences. From the same RNA sources six different N-terminal partial clones, #5-1, #5-2, #6-1, #6-2,
#12, and 17&19, indicated the existence of GABAB1k. They share common 59 UTRs and partial N-terminal ORFs of GABAB1k and suggest that
GABAB1k exists in human, mouse, and rat. To clone the full ORF of GABAB1k, additional primers were designed at its possible 39 UTR region based on
other known isoform sequence analyses. Full ORF containing clones were cloned from human brain and mouse midbrain. Bottom two boxes show
clones which contain the full ORF (a&b, a&7, 3&7 in human and c&d in mouse).
doi:10.1371/journal.pone.0014044.g003
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levels in human and mouse brains
After cloning the novel GABAB1 forms, GABAB1k, GABAB1l,
GABAB1m, and GABAB1n, their mRNA expression levels were
compared with other known isoforms in brain.
Previous human cDNA microarrays had three GABAB1
probes, clones 2312175, 298231, and 300899 [9,10]. Clones
2312175 and 298231 aligned to exon 23, and clone 300899
aligned to intron 4. Our mouse cDNA microarray probe set had
six different GABAB1 probes [11]. Three probes aligned to 39
exons of the GABAB1 gene including exon 23, and the other three
probes contained intron 4. Therefore, the human and mouse
probe sets are two types that include exon 23 or intron 4 of
GABAB1 gene. Based on the probe sequence information, GB1
primer and probe sets of the previous GABAB1j expression
measurement experiments were used for quantitative real-time
PCR. GB2 and GB3 primer and probe sets were designed
(Figure 4A). GB1 sets targeting exon 22 and 23 junction
represented human and mouse cDNA microarray probes that
aligned to 39 exons of GABAB1 gene. They detect all known
GABAB1 isoforms except GABAB1j. Since they identify the two
major isoforms, GABAB1a and b, their expressions were expected
to be strong. Because GB1 probe sets were designed at the exon
junction, there is no possibility of false signals due to genomic
contamination. Among commercial primer and probe sets, GB1
sets also best represented the microarray probes that contain exon
23. GB2 sets were specific for other microarray probes containing
intron 4. The probes were human cDNA microarray clone 300899
and its mouse homologs. GB3 sets were designed within intron 4
and exon 6. The two primer sets, GB2 and GB3, were used to
measure mRNA levels of multiple overlapping splice variants (e.g.
primer set GB2 could detect expression of variants GABAB1j, k, l,
m, and n while primer set GB3 could detect GABAB1k, l, m, and
n except GABAB1j). Therefore, GB2 expression could include
GB3.
Quantitative real-time PCR experiments showed different
expression patterns between human and mouse brain. In both
species, GB2 and GB3 expression was less than GB1 (Figure 4B,
C). After comparing GB2 and GB3 expression with GB1, the
relative GB2 and GB3 expression in human was less than in mouse
(Figure 4B, C). The relative GB3 expression level difference
between human and mouse was 4.2 fold which was less than the
relative GABAB1j expression difference (25 fold) as shown in
Figure 2B.
Prefrontal cortex, frontal cortex, and motor cortex were also
used to characterize GB3 expression in human; GB3 expression
levels were not significantly different across the brain regions
(Figure 4D).
GABAB1k, GABAB1l, and GABAB1m function
The GABAB receptor is a heterodimeric (GABAB1 + GABAB2)
G protein coupled receptor. GABA binding to GABAB1 transfers
a signal through G proteins whose functions are linked to several
effectors, including GIRK. Thus, GIRK currents were measured
using two-electrode voltage clamp to evaluate the functions of the
new GABAB1 isoforms.
GABAB receptor responses were first measured in oocytes
expressing GABAB1a and GABAB2 along with GIRK1 and
GIRK2 with a range of GABA concentrations. 1 mM GABA was
the maximum response concentration. The EC50 was 1.9 uM, and
Hill slope was 0.59 (Figure 5A).
For functional characterization, GABAB1k, l, and m were
chosen because they have more functional domains than
GABAB1n. Various amounts of each isoform cDNA were injected
into oocytes together with GABAB2, GIRK1, and GIRK2. GIRK
currents were measured following the previous GABAB1a and
GABAB2 response measurement protocol (Figure 5B). However,
no oocyte showed GABA-evoked GIRK currents.
Although GABAB1k, l, and m combined with GABAB2 did not
induce GIRK currents, we asked if they might inhibit GABAB
receptor function. Each isoform cDNA was injected along with
GABAB1a, GABAB2, GIRK1, and GIRK2 into oocytes. For
vector controls, the same amount of vector (instead of the new
isoform) was injected along with GABAB1a, GABAB2, GIRK1,
and GIRK2 into the control oocytes. The new isoform- and
vector-injected oocytes were paired into groups based on injection
amount. Injection amounts varied from 0 to 15 times the amount
of GABAB1a injection (Figure 6). After 5 days of incubation,
GABA-evoked GIRK currents were measured. GABA, 3 mM - an
approximate EC100 for GABAB1a and GABAB2 receptors, was
used. For each batch of oocytes, individual GIRK currents from
the isoform-expressing group were normalized as a percentage of
the average current of the vector control group. For nonparamet-
ric test, log10 values were calculated for the individual percentage
values. One-way ANOVA and Dunnett’s tests showed significant
effects of GABAB1l and m (p=0.006 and p=0.004, respectively);
however, GABAB1k did not show significant effects (Figure 6A, B,
C). For GABAB1l and m data, one-tailed unpaired Student’s
t-tests were performed between no isoform injection data (06) and
the other individual data (0.16 , 156). GABAB1l significantly
decreased GIRK currents at 56 and 66 of the GABAB1a
concentration (**p=0.0014 and *p=0.023, respectively;
Figure 6B). GABAB1m also evoked significant decreases at 116
and 126 of the GABAB1a concentration (***p=0.0003 and
**p=0.0064, respectively; Figure 6C). Among 9 to 12 different
oocyte batches, the inhibitory patterns were consistently observed.
Except for the GABAB1l and m injection ranges that decreased
GIRK currents, other injection amounts did not show the
inhibitory effects. This pattern was also observed at additional
injection amounts (86of GABAB1k, 4.56and 5.56of GABAB1l,
and 86of GABAB1m). In the GABAB1l inhibition range (56,
66of the GABAB1a concentration), 5.56also decreased GIRK
current. The other injection amounts did not produce inhibition
(data not shown), as expected from the inhibitory range shown in
Figure 6.
Discussion
In this study, novel GABAB1 splicing variants containing the
intron 4 region were cloned from human and mouse confirming
and extending the previous suggestion that this intron is a frequent
alternative splicing spot in the rat [6,7,13]. Previous studies cloned
GABAB1g, i, and j from rat, all of which have a portion of intron 4
[6,7,13]. However, intron 4 containing GABAB1 splicing variants
were not previously reported from human or mouse. Our
quantitative real-time PCR data implied that intron 4 is also an
alternative exon in human and mouse. Therefore, mouse
GABAB1j clones were found from the cDNA microarray probe
set. Though human GABAB1j was not cloned in this study, its
existence was confirmed by quantitative real time PCR. From
human and mouse, four more intron 4 containing clones were
identified. GABAB1k, l, m, and n were cloned from human, and
another GABAB1k was also cloned from mouse. Our study further
emphasizes that intron 4 is a frequent splicing spot of the GABAB1
gene in multiple species.
Though expression levels of these novel isoforms in total brain were
lower than other abundant isoforms (GABAB1a and b), they may be
preferentially expressed in specific cell types just as GABAB1a and
Novel GABAB1 Isoforms
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and are localized in the different cells using their own unique
promoters [3,5]. In cerebellum, GABAB1a is predominantly
expressed in granule cells, and GABAB1b is abundant in Purkinje
cells [4]. Like GABAB1a and GABAB1b, there are many other
precedents for N-terminal truncated splicing variants that have their
own promoters and show spatially different expression patterns
[15,16,17,18,19]. The novel isoforms are also N-terminal truncated
splicing variants and probably use specific promoters for their
expression. After identifying GABAB1 gene putative transcription
factor binding sites from the PROMO website, possible promoter
regions were found on exon 4 and the 59 part of intron 4 (data not
shown) [20,21]. Thus, the novel isoforms may be restricted to specific
cell types and inhibit GABAB receptor function.
Figure 4. The expression of GABAB1 isoforms. A. For quantitative real-time PCR, primer and probe sets were designed from human and mouse.
GB1 sets were designed by the last two exons, exon 22 and 23, and were used for detecting most known GABAB1 isoforms except GABAB1j. They also
represented the microarray probes that aligned to 59 exons of GABAB1 gene. GB2 sets were for detection of GABAB1j, k, l, m, and n. They aligned to
intron 4 and designed for human cDNA microarray probe, clone 300899, and its mouse homologous probes. GB3 sets targeted intron 4 through exon 6
and were specific for GABAB1k, l, m, and n. B. In human brain, GB1 showed much more dominant expression than GB2 and GB3. C. GB1 expression was
also stronger than GB2 and GB3 in mouse brain. However, GB2 and GB3 expression levels in mouse brain were much higher than human brain if they
were compared with GB1 expressions. D. In human, GB3 expressions were similar in prefrontal cortex, frontal cortex, and motor cortex.
doi:10.1371/journal.pone.0014044.g004
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also lack transmembrane domains and have the same C-terminal
truncated patterns as GABAB1e [8]. This phenomenon has been
observedfor splicing variantsof Interleukin-15 receptora, Fibroblast
growth factor receptor 4, human GABAB1e, and rat GABAB1j
which lose transmembrane domains by alternative splicing and are
secreted [7,8,22,23]. Our functional studies used continuous
perfusion of the oocytes, and it is possible that GABAB1l and m
were secreted and washed away resulting in low intracellular and
extracellular concentrations and obscuring some functional effects.
However, many secreted splicing variants including the C-terminal
truncated GABAB1 isoforms inhibit the functions of their other
membrane-bound isoforms [7,8,22,23,24].Itis possible that secreted
GABAB1l, m, and n could also inhibit GABAB receptor function.
The inhibitory effects of GABAB1l and m were found only
within a narrow concentration window of injected cDNA. The
reasons are not clear, but it is not likely due to nonspecific artifact
or toxicity with the highest amounts injected. Therefore, above the
optimal concentration window, their effects were diminished. The
vector controls also had the same injection amounts, but their
GABA responses were constant and stable. Also, the inhibitory
effects were seen consistently among all 9–12 different oocyte
batches. Some genes require optimal expression levels to display
their functional properties [25,26,27], and GABAB1m and n may
also need optimal expression ranges to inhibit function.
GABAB1e binds GABAB2 though a dimerization motif (166–
439 aa of GABAB1e) and appears to dominantly bind GABAB2 as
well as competing with GABAB1a [8]. Its dimerization motif is not
sushi domains but the rest of the N-terminal extracellular domain.
GABAB1k, l, m, n, but not GABAB1j contain the dimerization
motif and would be expected to bind GABAB2 dominantly instead
of GABAB1a and even reduce receptor function.
In summary, alternative splicings at intron 4 generate novel
isoforms, GABAB1j, k, l, m, and n (Figure 1A). The relative
mRNA expression patterns of GABAB1k, l, m, and n are more
conserved than GABAB1j across species when compared to
general GABAB1 isoform expression. However, the expression of
novel N-terminal splicing variants, GABAB1k, l, m, and n, is low
in whole brain (Figure 4D). They may have restricted expression at
specific cell types because they have putative promoter sites.
Though GABAB1k, l, m, and n are expected to dominantly
dimerize with GABAB2 like GABAB1e, only GABAB1l and m
were observed to disrupt the function of GABAB1a and 2.
GABAB1e has only C-terminal truncation [8], but the GABAB1l
and m have both C-terminal and N-terminal truncated patterns
(Figure 1B). Therefore, this additional N-terminal truncated
pattern may increase their inhibitory functions.
This work expands evidence for the diversity of GABAB1 splice
variants in brain. It is important to note that variants were found
in multiple species, and it has been noted that splice variants which
are likely to contribute to evolution and have functional value are
conserved across species [28]. In considering possible functional
roles of these splice variants, we should note that GABAB
receptors provide diverse neuronal signaling through G proteins
and may have additional functions as they form complexes with
other proteins [29].
Materials and Methods
Sequence analysis
To predict two possible isoforms, GABAB1j and GABAB1k,
SOURCE (http://smd.stanford.edu/cgi-bin/source/sourceSearch)
was used to search the sequence of the microarray probe, clone
300899. The sequence was converted to a FASTA format by EditSeq
Figure 5. GABAB1a/2 concentration response curve. A. cDNA and cRNA double injections were performed. For cDNAs, both GABAB1a and
GABAB2 were injected into the nucleus of Xenopus oocytes. GIRK1 and GIRK2 cRNAs were also injected into the cytosol of the same oocytes. Current
response of GABAB receptor and GIRK expressing oocytes were measured by two-electrode voltage clamp. 1 mM GABA was the maximum response
concentration; EC50 was 1.9 uM; Hill slope was 0.59. B. For GABAB1a/2 concentration response curve measurement, GABA dissolved in 49 mM HK was
applied for 1 min following a 2 min 49 mM HK application. After 2 additional min of 49 mM HK application, a 20 min wash with ND96 was followed.
doi:10.1371/journal.pone.0014044.g005
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Blast N Search (www.ncbi.nlm.nih.gov/blast) showed where the
probe aligned in GABAB1 gene. Its multiple stop codons were
founded from six different translated frames using MapDraw
programs of DNASTAR.
To compare GABAB1 isoform sequences, their sequences and
exon-intron structure information were found from NCBI data
base (http://www.ncbi.nlm.nih.gov). Their sequences were
aligned with MegAlign programs of DNASTAR, and their
conserved domains were searched by ExPASy Proteomics Server
(http://expasy.org) and CD-Search (http://www.ncbi.nlm.nih.
gov/Structure/cdd/wrpsb.cgi). To align GABAB1j sequences,
ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/index.html)
were used.
Figure 6. The functional effects of three novel human isoforms, GABAB1k, l, and m. Inhibitory effects were measured in Xenopus oocytes 5
days after injectingGABAB1a, GABAB2 cDNA andGIRK1, GIRK2 cRNA along with GABAB1k, l, or m cDNA. For vector controls, vectors were injectedin the
same amounts as used for the isoforms. Isoform and vector injection amounts varied from 0 to 15 times of GABAB1a injection amount. Used GABA
concentration was 3 mM, an approximate maximum response concentration. For each batch, individual GIRK currents from isoform injected oocytes
were normalized to percentage by the average vector control current. For nonparametric tests, the individual percent values were changed to log10.
After one-way ANOVA and Dunnett’s tests, one-tailed unpaired Student’s t-tests were performed between no isoform injected groups and the isoform
injected groups. A. GABAB1k had no inhibitory effect. B. GABAB1l data showed significant differences by ANOVA and Dunnett’s tests (p=0.0058), and
caused significantly decreased GIRK currents at 56and 66GABAB1l (**p=0.0014 and *p=0.0229, respectively). C. ANOVA and Dunnett’s tests showed
the significant differences of GABAB1m data (p=0.0040). GABAB1m showed significant decreases at 116 and 126 GABAB1m (***p=0.0003 and
**p=0.0064, respectively). The numbers of recorded oocytes are shown above the bars by each group. Data are expressed as the mean 6 SEM.
doi:10.1371/journal.pone.0014044.g006
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To determine the existence of novel GABAB1 isoforms,
GABAB1j and GABAB1k, across species, the microarray probe,
clone 300899, was cloned from human, and its homologous
regions were also cloned from mouse and rat based on Blast N
Search. For further examination, partial GABAB1k clones were
identified. The partial GABAB1k clones contain the microarray
probe and GABAB1k unique region, 39 intron 4 of GABAB1a. For
these experiments, total RNA was isolated from human cultured
cells, including HEK-293 (ATCC, Manassas, VA, USA), SH-
SY5Y (ATCC, Manassas, VA, USA), and SK-N-SH (ACTT,
Manassas, VA, USA). Total RNA was also isolated from mouse
midbrain and rat hippocampus. After treating DNase (Qiagen,
Valencia, CA, USA), cDNAs were made using oligo(dT) primer
(Invitrogen, Carlsbad, CA, USA). To clone the microarray probe,
primers were designed within the probe region using Primer3
(http://frodo.wi.mit.edu/primer3/) and PrimerSelect program of
DNASTAR. For partial GABAB1k cloning, the probe region and
other 39 exons were be targeted to design primers. PCRs were
performed using the primers and the prepared human, mouse, and
rat cDNAs.
PCR primers (59 to 39):
- Human
Not1-hGABBR1iso-probe-S: AAGGAAAAAAGCGGCCGC-
CCTTCTTCAGGTTTAAATACTCCA
Sal1-hGABBR1iso-probe-A: ACGCGTCGACCCATCGAG-
CCCTCTATATTATTAG
Not1-hGABBR1iso-#1probe-S1: AAGGAAAAAAGCGGCC-
GCCTTGGGCTTTACTTTCCTCACAT
Sal1-hGABBR1iso-#2probe-A1: ACGCGTCGACGAATCT-
ACCAGGGTAGAGGAAGT
Sal1-hGABBR1-A: ACGCGTCGACCTTGATAGGGTCGT-
TGTAGAGC
Sal1-hGABBR1-A1: ACGCGTCGACAGAGTCGAAGTGA-
AGACCTCAG
- Mouse
Cla1-mGABBR1iso-probe-S: CCATCGATTAGACTTAGA-
ACATCCTCTGTATCA
Cla1-mGABBR1iso-probe-A: CCATCGATAGAGTTTGGG-
TGCCCAGAAAAG
Cla1-mGABBR1-A: CCATCGATGGATAAGCTTGAGCT-
CGTAGTC
- Rat
Not1-rGABBR1iso-probe-S: AAGGAAAAAAGCGGCCGCC-
CCTCTCTGTAGATGTAGAACATT
Sal1-rGABBR1iso-probe-A: ACGCGTCGACTTCTGGTCA-
TTCTGCCCCAACT
Sal1-rGABBR1-A: ACGCGTCGACGGATAAGCTTGAGC-
TCGTAGTC
Cloning novel isoforms, GABAB1k, GABAB1l, GABAB1m,
and GABAB1n
To clone full ORFs of the novel isoforms, cDNAs were
generated with oligo(dT) primer from human brain total RNA
(Ambion, Austin, TX, USA) and mouse midbrain total RNA.
Primers were designed based on intron 4 of GABAB1a and
common 39 UTR of known isoforms, and PCRs were performed
using the human and mouse brain cDNAs.
PCR primers (59 to 39):
- Human
Not1-hGABBR1iso-#1probe-S1: AAGGAAAAAAGCGGCC-
GCCTTGGGCTTTACTTTCCTCACAT
Sal1-hGABBR1-A2: ACGCGTCGACGGTAACTAGAAGA-
GGGTGTTGC
Not1-hGABBR1cl-CD-S: AAGGAAAAAAGCGGCCGCTC-
TTCTCTGATCCCCGTCTTT
Sal1-hGABBR1cl-CD-A: ACGCGTCGACTACTGGCCTG-
TCCTCCCTC
- Mouse
Cla1-mGABBR1cl-CD-S: CCATCGATTTCTCTGATCCC-
CGTCTTTC
Cla1-mGABBR1cl-CD-A: CCATCGATTGCTGGCCTCAT-
CCTTCTC
Quantitative real-time PCR
TaqManH Gene Expression Assays and Custom TaqManH
Gene Expression Assays (Applied Biosystems, Foster City, CA,
USA) were used to detect GABAB1 isoform expressions. cDNA
microarray probes are two different kinds containing exon 23 or
intron 4. The probes containing exon 23 detect all known isoform
expressions except GABAB1j. The exon 22–23 junction was
targeted using predesigned TaqManH Gene Expression Assays.
Custom TaqManH Gene Expression Assays were used for intron 4
containing probes, and thus were able to detect GABAB1j,
GABAB1k, GABAB1m, GABAB1l, and GABAB1n. Using the
same method, the unique alternative splicing region of GABAB1k,
GABAB1m, GABAB1l, and GABAB1n were targeted, and
GABAB1j specific expression was also detected. For endogenous
control gene, beta-glucuronidase (GUSB) was used.
After making cDNAs with random primers (Invitrogen,
Carlsbad, CA, USA), quantitative real-time PCR was performed.
Isoform expressions were compared between human and mouse
whole brain RNAs (Ambion, Austin, TX, USA). To measure
isoform expression differences in select human brain regions,
RNAs from whole brain, prefrontal cortex, frontal cortex
(Ambion, Austin, TX, USA), and motor cortex [30] were used.
cDNA and cRNA preparation
To do injections into Xenopus oocytes for electrophysiological
recordings, cDNAs and cRNAs were prepared. For cDNA
injection, human GABAB1a clone in pcDNA3.1(2) vector
(Invitrogen, Carlsbad, CA, USA) and human GABAB2 clone in
pcDNA3 vector (Invitrogen, Carlsbad, CA, USA) were kindly
provided by Dr. Uezono (Nagasaki University, Nagasaki, Japan)
with the permission of GlaxoSmithKline (Brentford, Middlesex,
UK). The cDNAs encoding novel human GABAB1 isoforms,
GABAB1k, GABAB1l, and GABAB1m, were also subcloned into
pcDNA3.1(2) vector. The cRNAs for GIRK1 and GIRK2 were
synthesized as described previously for cRNA injections [31].
Electrophysiological recording
For electrophysiological recordings, oocytes from Xenopus laevis
frog were used. The frog was used according to the National
Institutes of Health guide for the care and use of laboratory
animals.
To form functional receptors, nuclear injection of GABAB1a and
GABAB2 cDNAs were performed intoXenopus oocytes with 0.75 ng
and 0.63 ng, respectively. GIRK1 (0.2 ng) and GIRK2 (0.2 ng)
cRNAs were also injected into the cytosol of the same oocytes in
order to measure GABAB receptor-induced currents. Total
injection volumes of cDNAs and cRNAs were 60 nl. Electrophys-
iological recordings were made with the oocytes after 5 to 7 day
incubation at 19uC. Using two-electrode voltage clamp, the oocytes
were clamped at 260 mV while being perfused (2 ml/min) with
ND96 buffer (in mM: 96 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2,5
HEPES, pH7.5). A 49 mM high-K
+ solution (49mM HK) (in mM:
48 NaCl, 49 KCl, 1 CaCl2, 1 MgCl2, 5 HEPES, pH7.5)was applied
to the oocytes for 2 min [32]. GABA (Sigma, St. Louis, MO, USA),
Novel GABAB1 Isoforms
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49 mM HK and applied for 1 min. ND96 was applied for 20 min
following the 2 min application of 49 mM HK.
The responses of GABAB1a and GABAB2 to the range of
GABA concentrations were used to generate GABA concentration
response curves with GraphPad Prism, Version 5.01 (GraphPad
Software, San Diego, CA, USA). EC50 and Hill coefficient values
were calculated from the GABA concentration response curves. A
maximally effective GABA concentration was also determined
from it and was used to test inhibitory effects of the isoforms.
To test if the isoforms can substitute for GABAB1a as a
functional receptor subunit, 0.63 ng GABAB2, 0.2 ng GIRK1,
and 0.2 ng GIRK2 were injected into oocytes with various
amounts (0.001 ng to 20 ng) of isoform cDNAs. Total injection
volumes were 60 nl. As in the GABA concentration response
experiment, GABA-evoked GIRK currents were measured to de-
termine receptor function.
To determine the inhibitory functions of isoforms, GABAB1a
was co-injected with each isoform. Except the isoforms, the
injection amounts of GABAB1a, GABAB2, GIRK1, and GIRK2
were the same as the GABA concentration response experiment.
For vector controls, the same amount of vector, pcDNA3.1(2),
was injected into control oocytes instead of the isoforms. Total
injection volumes were 60 nl. The isoform and vector injection
amounts varied from 0 to 15 times the GABAB1a injection
amount (0.75 ng). After a 5 day incubation at 19uC, GABA-
evoked GIRK currents were measured. The GABA concentration
was 3 mM which was the maximal concentration for GABA
responses in GABAB1a and GABAB2 expressing oocytes. Nine
batches of oocyte were used for both GABAB1k and m
experiments, and 12 batches were for GABAB1l. For each batch
of oocytes, individual GIRK currents in isoform injected oocytes
were expressed as a percentage of average current in vector
control oocytes. For nonparametric tests, log10 data were
calculated from the values.
Statistical analysis
For statistical analysis and graphing, GraphPad Prism and Excel
(Microsoft, Redmond, WA, USA) were used. For electrophysiol-
ogy data, one-way ANOVA tests and unpaired Student’s t-tests
were used to define statistical significances. Dunnett’s tests were
also used for post hoc tests.
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